This conclusion is supported by a recently published report (posted in bioRxiv) on the involvement of VIM in SARS-CoV-2 infection showing that treatment with an anti- VIM antibody can block infection of HEK-293 cells expressing ACE2 (44). Here, ACE2 is linked to infection.